Results 121 to 130 of about 660,420 (310)

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Copyright Protection In The Digital Era: A Malaysian Perspective

open access: yes
This paper seeks to explore the significance of copyright protection in Malaysia’s business environment of the digital era. Copyright law is increasingly being challenged with the intensification of internet use now.
Lee, Kaw May   +2 more
core  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Kenya Social Protection Policy 2023

open access: yes
Social Protection is becoming increasingly important worldwide as a powerful tool for combating poverty, inequality, and vulnerability to risks and contingencies across the life cycle, including shocks due to natural disasters, pandemics, and man-induced
Ministry of Labour and Social Protection
core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

La Víctima de Trata Sexual y su Des-protección en la Ley Integral contra la Violencia de Género 1/2004 (The Sexual Trafficking Victims and Des-protection in the Law Against Gender Violence 1/2004)

open access: yesOñati Socio-Legal Series, 2015
In this article I make a reflection about the art. 1 L0 1/2004 of 28 December of integral Protection Measures against Gender Violence (law 1/2004) and its relations with sexual trafficking victims, who are absent in these regulation, and as a result any ...
Izaskun Orbegozo
doaj  

Assessment of Health Professionals' Attitudes on Radiation Protection Measures. [PDF]

open access: yesInt J Environ Res Public Health, 2021
Goula A   +5 more
europepmc   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

open access: yesMolecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy